2. Abstract
Objective To analyze and compare the number of sympathectomies for the treatment of hyperhidrosis in the public health system (SUS - Unified Health System) before, during, and after the peak of the COVID-19 pandemic in Brazil.
Method A retrospective cross-sectional study, in accordance with the guidelines of the Research Ethics Committee, which analyzed the number of elective surgical procedures performed in SUS-Brazil, including the number of thoracic sympathectomies for the treatment of hyperhidrosis, in the 2 years prior to the COVID-19 pandemic (2018 and 2019) as well as in the 2 years of maximum prevalence (2020-2021) and in the 2 years following the peak of cases (2022-2023). The data analyzed was obtained from the database of the Department of Informatics of the Unified Health System (DATASUS).
Results The number of thoracic sympathectomies performed in the SUS during the years 2020 and 2021 significantly decreased, probably secondary to the allocation of resources to the care of COVID-19 patients. This was followed by a lower than expected increase in the number of sympathectomies compared to pre-pandemic data.
Conclusion The volume of sympathectomies, and consequently the surgical treatment of hyperhidrosis patients dependent on the SUS, have been extremely affected by the COVID-19 pandemic and remain in slow recovery, with no short-term prospect of returning to previous figures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No author has conflict of interest. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data was extracted from the DATASUS portal (Department of Information and Informatics of the Brazilian Unified Health System) where it is stored anonymously and is available for free consultation. https://datasus.saude.gov.br/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript All data analyzed are available online at https://datasus.saude.gov.br/
